alcohol withdrawal delirium: An acute organic mental disorder induced by cessation or reduction in chronic alcohol consumption. Clinical characteristics include confusion; delusions; vivid hallucinations; tremor; agitation; insomnia; and signs of autonomic hyperactivity (e.g., elevated blood pressure and heart rate, dilated pupils, and diaphoresis). This condition may occasionally be fatal. It was formerly called delirium tremens. (From Adams et al., Principles of Neurology, 6th ed, p1175)
Mental and behavioural disorders due to use of volatile solvents
DOID EFO Endpoint Browser PheWeb
F5_SOLVENT
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
107 |
4. Check minimum number of eventsNone |
107 |
5. Include endpointsNone |
107 |
6. Filter based on genotype QC (FinnGen only) |
107 |
Control definitions (FinnGen only)
- Control exclude
- F5_SUBSNOALCO
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F10-F19
- Name in latin
- Perturbationes mentis et modi se gerendi ex usu solventium volatilium
Similar endpoints
↥List of similar endpoints to
Mental and behavioural disorders due to use of volatile solvents
based on the number of shared cases.
Similar with more cases:
- Substance use, excluding alcohol
- Substance abuse, excluding more controls
- Substance abuse
- Mental and behavioural disorders due to psychoactive substance use
- Any mental disorder
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1225 | 317 | 902 |
| Only index persons | 1060 | 291 | 769 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.01 | 0.03 |
| Only index persons | 0.02 | 0.01 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 28.99 | 26.78 | 29.71 |
| Only index persons | 28.18 | 26.16 | 28.94 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 107 | 39 | 68 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.03 |
| Median age at first event (years) | 28.22 | 25.49 | 29.79 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 97
- Matched controls
- 967
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B18.2
ICD-10 Finland
Chronic viral hepatitis C
213.5
40.2
39
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
31.3
34.5
47
28
T36
ICD-10 Finland
Poisoning by systemic antibiotics
37.5
33.6
43
20
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
+∞
29.7
27
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
39.9
28.9
36
14
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
+∞
28.5
26
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
20.0
28.2
45
40
P19
ICPC
Drug abuse
+∞
27.4
25
*
F18.1
ICD-10 Finland
Mental and behavioural disorders due to use of volatile solvents, harmful use
+∞
26.2
24
*
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
+∞
26.2
24
*
N05AH03
ATC
olanzapine; systemic
19.4
25.8
41
35
N05AH04
ATC
quetiapine; oral
11.8
25.5
57
104
N07BB01
ATC
disulfiram; oral
30.3
22.6
30
14
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
+∞
21.7
20
*
F29
ICD-10 Finland
Unspecified nonorganic psychosis
21.1
21.3
32
22
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
12.1
20.2
40
53
P15
ICPC
Chronic alcohol abuse
44.8
20.0
24
7
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
+∞
19.4
18
*
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
+∞
18.3
17
*
F18.20
ICD-10 Finland
Dependence relationship caused by volatile solvents currently independent
+∞
18.3
17
*
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
32.9
17.9
23
9
N05BA01
ATC
diazepam; systemic, rectal
11.5
17.7
35
45
N05AX08
ATC
risperidone; systemic
12.6
16.2
30
33
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
+∞
16.1
15
*
3046A
ICD-9 Finland
Drug dependence, Other specified drug dependence
+∞
16.1
15
*
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
+∞
16.1
15
*
Z72.2
ICD-10 Finland
Drug use
+∞
16.1
15
*
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
35.4
15.9
20
7
N05AH02
ATC
clozapine; systemic
29.3
15.9
21
9
N03AE01
ATC
clonazepam; systemic
23.2
15.6
22
12
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
+∞
15.0
14
*
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
+∞
15.0
14
*
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
+∞
15.0
14
*
F10.20
ICD-10 Finland
Alcohol dependence currently independent
25.8
14.0
19
9
F10.25
ICD-10 Finland
Alcohol dependence continuous use
31.1
14.0
18
7
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
+∞
13.9
13
*
F11.21
ICD-10 Finland
Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment
+∞
13.9
13
*
P18
ICPC
Medication abuse
161.7
13.8
14
*
N06AX11
ATC
mirtazapine; oral
5.5
13.6
52
167
F10.09
ICD-10 Finland
Alcohol intoxication UNS
27.2
13.5
18
8
P16
ICPC
Acute alcohol abuse
29.0
13.0
17
7
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
80.8
13.0
14
*
F18.29
ICD-10 Finland
Dependence caused by volatile solvents UNS
+∞
12.8
12
*
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
19.3
12.8
19
12
N05AA02
ATC
levomepromazine; systemic
15.4
12.3
20
16
N05BA04
ATC
oxazepam; oral
5.4
11.9
43
125
N05BA12
ATC
alprazolam; oral
9.9
11.8
24
31
T40.6
ICD-10 Finland
Poisoning: Other and unspecified narcotics
+∞
11.7
11
*
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
7.1
11.6
30
57
N06AB04
ATC
citalopram; systemic
5.9
11.5
36
88
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
32.3
11.1
14
5
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
14.4
10.9
18
15
N05CD07
ATC
temazepam; oral
12.8
10.9
19
18
F32.9
ICD-10 Finland
Depressive episode, unspecified
6.1
10.9
32
72
AA1AD
NOMESCO Finland
CT of head and brain
6.3
10.8
31
67
F20.9
ICD-10 Finland
Schizophrenia, unspecified
15.5
10.6
17
13
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
37.1
10.6
13
*
F18.9
ICD-10 Finland
Mental and behavioural disorders due to use of volatile solvents, unspecified mental and behavioural disorder
+∞
10.6
10
*
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
+∞
10.6
10
*
F19.26
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction
+∞
10.6
10
*
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
12.1
10.6
19
19
Z2446
NOMESCO Finland
Social worker
9.2
10.4
22
30
R56.8
ICD-10 Finland
Other and unspecified convulsions
10.6
10.4
20
23
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
9.6
10.3
21
27
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
19.4
10.3
15
9
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
19.4
10.3
15
9
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
45.0
10.2
12
*
X57
ICD-10 Finland
Unspecified privation
45.0
10.2
12
*
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
14.5
9.8
16
13
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
20.1
9.7
14
8
A46
ICD-10 Finland
Erysipelas
7.2
9.7
24
42
SPAT1275
SPAT
Drug rehabilitation and replacement therapy of opioid-dependent person
110.3
9.6
10
*
N05BA02
ATC
chlordiazepoxide; systemic
110.3
9.6
10
*
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
+∞
9.5
9
*
T40.9
ICD-10 Finland
Poisoning: Other and unspecified psychodysleptics [hallucinogens]
+∞
9.5
9
*
F19.9
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder
+∞
9.5
9
*
F19.00
ICD-10 Finland
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
+∞
9.5
9
*
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
+∞
9.5
9
*
K04.5
ICD-10 Finland
Chronic apical periodontitis
4.4
9.4
41
139
EBA30
NOMESCO Finland
Excision of root of tooth
17.9
9.4
14
9
ZY010
NOMESCO Finland
Hospital outpatient
9.2
9.2
19
25
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
16.1
9.0
14
10
ZY000
NOMESCO Finland
Hospital inpatient
55.1
8.9
10
*
F10.24
ICD-10 Finland
Alcohol depence active use
18.5
8.8
13
8
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
30.6
8.7
11
*
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
98.2
8.6
9
*
Z3231
NOMESCO Finland
Registered nurse
4.1
8.6
40
143
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.2
8.5
28
70
P72
ICPC
Schizophrenia
16.4
8.5
13
9
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
+∞
8.4
8
*
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
+∞
8.4
8
*
F18.00
ICD-10 Finland
Intoxication caused by volatile solvents uncomplicated
+∞
8.4
8
*
F11.20
ICD-10 Finland
Addiction-induced dependence caused by opiates currently independent
+∞
8.4
8
*
N05CF01
ATC
zopiclone; oral
4.1
8.4
38
131
N06AX16
ATC
venlafaxine; oral
4.9
8.4
29
77
F61.0
ICD-10 Finland
Mixed personality disorders
19.3
8.3
12
7
F60.2
ICD-10 Finland
Dissocial personality disorder
36.7
8.2
10
*
SPAT1265
SPAT
Breathalyser
36.7
8.2
10
*
L17
ICPC
Foot/toe symptom/complaint
4.5
8.2
32
96
N03AG01
ATC
valproic acid; systemic, rectal
8.3
7.9
17
24
N05AD01
ATC
haloperidol; systemic
11.5
7.8
14
14
C07AA05
ATC
propranolol; systemic
4.4
7.8
31
94
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
27.5
7.7
10
*
Z2445
NOMESCO Finland
Psychologist
9.6
7.7
15
18
F99
ICD-10 Finland
Mental disorder, not otherwise specified
15.0
7.6
12
9
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
86.4
7.5
8
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.7
7.5
27
74
F19.30
ICD-10 Finland
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated
+∞
7.4
7
*
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
+∞
7.4
7
*
F19.09
ICD-10 Finland
Intoxication caused by several drugs in combination and by other psychoactive substances UNS
+∞
7.4
7
*
F19.59
ICD-10 Finland
Psychotic disorder caused by several drugs in combination and by other psychoactive substances UNS
+∞
7.4
7
*
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
+∞
7.4
7
*
F20
ICD-10 Finland
Schizophrenia
32.7
7.3
9
*
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
9.4
7.1
14
17
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
9.4
7.1
14
17
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
12.2
7.0
12
11
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
12.2
7.0
12
11
N05AF03
ATC
chlorprothixene; systemic
12.2
7.0
12
11
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
43.2
6.9
8
*
Y07
ICD-10 Finland
Other maltreatment
43.2
6.9
8
*
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
24.5
6.8
9
*
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
13.6
6.8
11
9
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
3.1
6.7
64
370
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
74.5
6.5
7
*
B18.1
ICD-10 Finland
Chronic viral hepatitis B without delta-agent
74.5
6.5
7
*
SPAT1247
SPAT
Outpatient detoxication and monitoring
74.5
6.5
7
*
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
12.2
6.5
11
10
N06AX12
ATC
bupropion; oral
5.4
6.4
19
42
KMAK
NOMESCO Finland
NA
3.2
6.4
71
450
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
28.7
6.3
8
*
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
+∞
6.3
6
*
F15.3
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, withdrawal state
+∞
6.3
6
*
F11.30
ICD-10 Finland
Withdrawal symptoms caused by opiates uncomplicated
+∞
6.3
6
*
WX730
NOMESCO Finland
Conventional respirator
+∞
6.3
6
*
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
+∞
6.3
6
*
F05.9
ICD-10 Finland
Delirium, unspecified
+∞
6.3
6
*
SPAT1272
SPAT
Drug screening
+∞
6.3
6
*
F19.2
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome
+∞
6.3
6
*
Z03
ICPC
Housing/neighbourhood problem
+∞
6.3
6
*
F15.0
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, acute intoxication
+∞
6.3
6
*
N03AX16
ATC
pregabalin; oral
4.4
6.3
23
64
T74.1
ICD-10 Finland
Physical abuse
13.7
6.2
10
8
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
11.1
6.2
11
11
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
11.1
6.2
11
11
WX290
NOMESCO Finland
Other blockade of nerve
3.0
6.0
66
403
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3028707) Methadone [Presence] in Urine by Screen method
44
29
25.07
53.44
7.7
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
50
60
14.77
42.35
6.3
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
52
79
11.86
36.58
7.9
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
53
86
11.23
35.26
8.2
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
53
87
11.09
34.89
8.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
53
87
11.09
34.89
7.9
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
43
55
12.40
34.19
8.8
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
52
86
10.82
33.92
8.1
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
34
6
81.80
31.34
2.0
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
20
14
17.34
22.53
30.8
16.0
nmol/l
1344.5
1133.6
0.40
20
14
(4198724)
24
5
61.09
21.18
3.6
1.8
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
17
10
20.02
20.73
2.7
1.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
58
196
5.28
16.65
7.3
3.2
mmol/l
7.9
8.7
0.40
51
173
(3000991) Gas panel - Venous blood
27
46
7.51
16.17
10.3
5.7
—
—
—
0
0
(3012544) pH of Venous blood
28
53
6.80
15.14
4.2
3.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
25
47
6.64
13.52
1.6
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
50
177
4.43
12.92
13.1
7.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
46
153
4.52
12.91
6.1
4.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
48
169
4.34
12.42
1.8
1.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
19
29
7.75
12.37
11.3
3.5
mmol/l
26.1
24.0
1.42
19
29
(3007853) Bacteria identified in Skin by Aerobe culture
34
92
4.95
12.31
2.2
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
30
7.48
12.00
1.4
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
26
59
5.50
11.47
6.1
2.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
35
104
4.52
11.19
1.9
1.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
55
230
3.86
10.88
7.7
6.2
—
—
—
0
0
(3015736) pH of Urine
64
297
3.87
10.82
5.4
2.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
74
381
4.06
10.65
12.0
6.2
e9/l
0.6
0.5
1.52
65
344
(3006315) Basophils [#/volume] in Blood
74
382
4.04
10.59
12.0
6.2
e9/l
0.0
0.0
0.17
65
348
(3013115) Eosinophils [#/volume] in Blood
75
393
4.04
10.45
14.5
6.4
e9/l
0.2
0.2
0.61
67
361
(3019198) Lymphocytes [#/volume] in Blood
76
402
4.07
10.43
12.3
6.1
e9/l
2.2
1.9
2.23
68
371
(3024928) Oxygen saturation in Venous blood
13
5
29.23
10.08
2.8
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
80
453
4.04
9.59
24.2
9.2
e9/l
4.5
4.1
0.78
71
405
(3024561) Albumin [Mass/volume] in Serum or Plasma
59
276
3.54
9.53
4.7
4.6
g/l
35.6
38.0
1.99
54
264
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
53
237
3.45
9.11
2.1
1.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
59
286
3.37
8.82
7.6
5.4
mmol/l
1.2
1.2
0.81
52
244
(3013826) Glucose [Moles/volume] in Serum or Plasma
76
430
3.65
8.82
9.2
3.6
mmol/l
6.9
6.6
0.46
71
394
(3021589) Normoblasts [#/volume] in Blood
67
363
3.26
8.10
13.3
7.9
e9/l
0.0
0.0
0.44
53
305
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
16
32
5.70
7.94
13.2
6.3
%
0.7
0.7
0.26
16
32
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
16
33
5.53
7.69
13.2
6.2
%
1.7
2.0
0.19
16
33
(46235355) HIV 1 and 2 tests - Meaningful Use set
59
309
3.03
7.37
3.3
2.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
50
241
3.02
7.22
3.9
3.0
e6/l
33.0
100.2
0.44
30
172
(3023511) Choriogonadotropin [Units/volume] in Urine
15
31
5.46
7.17
1.9
1.2
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
6
0
+∞
6.30
6.0
0.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
46
229
2.77
6.05
3.3
2.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
25
96
3.09
5.18
2.0
2.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
38
184
2.65
5.14
3.9
3.1
ph
7.4
7.4
—
9
31
(3002582) Erythrocytes [#/volume] in Urine
41
207
2.59
5.09
3.1
2.4
e6/l
76.5
56.0
0.12
30
161
(44816559) Phosphatidylethanol [Mass/volume] in Blood
14
38
4.09
4.82
1.7
1.4
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
21
79
3.06
4.48
5.7
5.6
mmol/l
1.0
1.0
0.33
21
74
(3011397) Hemoglobin [Presence] in Urine by Test strip
34
166
2.54
4.45
2.9
3.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
31
4.23
4.39
1.7
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
23
4.69
4.18
1.3
1.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
36
186
2.41
4.14
3.1
2.4
e6/l
0.5
0.2
0.47
25
139
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
40
220
2.31
3.98
1.6
1.7
pmol/l
107.8
98.8
0.43
26
121
(3044889) 12 lead EKG panel
71
498
2.27
3.86
4.0
2.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
11
30
3.97
3.74
19.5
6.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
42
245
2.18
3.56
7.3
4.7
inr
1.2
1.1
0.34
12
73
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
29
145
2.37
3.54
1.6
1.8
mg/l
3.9
2.8
0.55
24
124
(36304419) Bacteria [Presence] in Urine
35
190
2.25
3.53
3.2
2.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
77
569
2.26
3.53
3.6
3.7
pmol/l
14.6
14.7
0.08
71
530
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
22
98
2.57
3.41
2.6
2.3
e6/l
7.3
1.0
—
8
49
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
24
116
2.38
3.13
2.3
2.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
13
46
3.08
3.04
1.9
1.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
71
525
2.05
3.03
4.0
3.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
9
22
4.37
2.95
2.2
2.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
10
31
3.46
2.85
5.2
2.4
%
1.5
2.0
—
10
31
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
23
4.17
2.84
1.3
1.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
14
54
2.83
2.83
5.6
3.8
%
0.5
0.5
—
6
12
(3009261) Glucose [Presence] in Urine by Test strip
56
389
1.92
2.78
3.3
2.8
estimate
0.0
0.0
0.00
11
71
(3021960) Folate [Moles/volume] in Serum or Plasma
25
131
2.19
2.69
1.4
1.5
nmol/l
20.5
20.0
0.06
25
115
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
35
209
2.00
2.69
2.9
2.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
55
383
1.90
2.68
4.5
3.9
estimate
0.0
0.0
0.00
11
75
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
20
97
2.31
2.57
1.8
2.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
55
387
1.87
2.57
3.4
2.7
estimate
0.0
0.0
0.00
11
74
(3026008) Bacteria identified in Urine by Culture
29
167
2.01
2.44
3.0
2.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
13
53
2.65
2.38
2.7
2.6
u/l
3835.1
97.3
—
5
20
(3004119) Hemoglobin [Mass/volume] in Venous blood
10
35
3.05
2.37
5.2
2.3
g/l
129.2
138.2
—
10
35
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
13
4.82
2.30
1.3
1.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
13
4.82
2.30
1.3
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
21
357
0.49
2.28
2.4
2.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
17
81
2.31
2.27
1.6
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
36
229
1.86
2.25
3.3
2.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
17
82
2.28
2.21
1.7
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
9
30
3.18
2.20
10.2
3.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
32
199
1.87
2.13
16.2
4.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
21
113
2.07
2.10
1.8
1.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
12
51
2.52
2.03
6.3
3.8
%
0.0
0.0
—
5
9
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
11
4.71
1.96
1.2
1.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
33
214
1.78
1.91
3.5
1.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
20
110
2.01
1.89
2.7
2.2
e6/l
3.0
0.7
—
6
61
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
90
776
2.01
1.88
17.8
8.2
ml/min/173m2
104.0
96.2
2.68
75
633
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
8
31
2.71
1.69
1.9
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
19
3.28
1.68
2.2
2.7
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
19
3.28
1.68
1.2
1.1
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
5
14
3.69
1.63
18.8
2.3
kpa
8.2
10.1
—
5
14
(3013290) Carbon dioxide [Partial pressure] in Blood
5
14
3.69
1.63
18.8
2.3
kpa
5.9
4.9
—
5
14
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
25
156
1.79
1.62
2.6
1.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
100
916
2.40
1.59
17.1
8.8
—
—
—
0
0
(3020891) Body temperature
7
28
2.60
1.48
8.7
3.9
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
22
2.83
1.45
1.5
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
35
247
1.62
1.45
3.2
2.5
ng/l
54.8
26.8
0.27
20
128
(1616796) Gas panel - Central venous blood
5
17
3.03
1.37
13.2
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
15
86
1.87
1.27
1.8
1.4
—
—
—
0
0
(3010421) pH of Blood
5
19
2.71
1.23
18.8
2.1
ph
7.4
7.4
—
5
14
(3022217) INR in Platelet poor plasma by Coagulation assay
10
50
2.10
1.21
2.5
16.5
—
1.4
—
0
7
(3048689) Calprotectin [Mass/mass] in Stool
6
125
0.45
1.13
1.0
2.6
ug/g
559.5
113.5
—
6
100
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
32
2.27
1.10
1.3
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
9
45
2.09
1.08
4.6
1.6
%
1.4
1.7
—
9
40
(4010399)
9
46
2.04
1.07
1.4
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
19
126
1.62
1.00
2.3
3.0
ng/l
18.0
104.1
—
10
79
(3029937) Albumin [Presence] in Urine by Test strip
28
207
1.48
0.92
3.7
2.7
estimate
0.0
0.0
0.49
11
74
(3002256) Pathology report gross observation
12
73
1.73
0.86
1.3
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
93
862
1.60
0.85
29.1
10.1
%
40.0
41.9
1.63
71
730
(4034850)
6
32
1.93
0.83
16.3
15.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
8
131
0.58
0.80
2.8
2.1
ug/l
0.4
0.6
—
8
59
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
42
345
1.36
0.76
3.8
3.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
5
26
1.97
0.71
1.2
2.6
%
172.2
161.7
—
5
26
(3012516) Albumin [Mass/volume] in Urine
20
146
1.45
0.70
3.2
3.8
mg/l
25.5
90.9
1.40
15
95
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
5
27
1.89
0.69
1.2
2.2
g/l
3.9
3.4
—
5
27
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
11
71
1.61
0.65
7.5
7.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
31
249
1.34
0.64
1.6
1.6
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
21
0.00
0.60
0.0
1.3
—
9.6
—
0
9
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
0
22
0.00
0.60
0.0
1.2
—
4.8
—
0
13
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
24
188
1.36
0.58
1.3
1.7
mg/l
0.7
1.0
0.62
14
138
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
11
156
0.67
0.55
1.1
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
9
64
1.44
0.53
3.7
2.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
7
47
1.52
0.48
1.0
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
24
194
1.31
0.47
2.2
1.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
13
171
0.73
0.43
3.8
2.6
%
7.9
20.3
—
6
52
(40768804) Tissue Pathology biopsy report
22
267
0.78
0.43
1.6
1.8
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
5
32
1.59
0.43
6.6
2.8
%
51.3
57.1
—
5
32
(40761535) Cells panel - Urine sediment
8
58
1.41
0.42
3.5
2.6
—
—
—
0
0
(3000492) Spirometry study
7
103
0.66
0.42
1.1
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
0
15
0.00
0.41
0.0
3.0
—
1.0
—
0
15
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
3.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
15
0.00
0.41
0.0
3.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
17
0.00
0.41
0.0
2.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
18
0.00
0.40
0.0
1.4
—
7.4
—
0
11
(4268621)
0
18
0.00
0.40
0.0
2.4
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
18
0.00
0.40
0.0
1.2
—
94.1
—
0
18
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(4094501)
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
35
309
1.20
0.33
3.4
2.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
30
267
1.17
0.25
1.5
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
11
136
0.79
0.25
1.5
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
10
79
1.29
0.23
1.0
1.3
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
0
11
0.00
0.21
0.0
3.5
—
0.0
—
0
11
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
11
0.00
0.21
0.0
3.5
—
0.0
—
0
11
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
0
12
0.00
0.21
0.0
2.3
—
7.1
—
0
12
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
3.6
—
15.2
—
0
12
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
13
0.00
0.21
0.0
1.8
—
7.2
—
0
6
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
13
0.00
0.21
0.0
5.8
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
13
0.00
0.21
0.0
2.9
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
13
0.00
0.21
0.0
3.2
—
10.4
—
0
13
(4035726)
6
48
1.26
0.20
1.3
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
0
14
0.00
0.20
0.0
3.1
—
0.0
—
0
14
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
5
65
0.76
0.17
1.0
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
85
833
1.10
0.10
4.3
3.6
mmol/l
2.6
2.9
2.55
80
791
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
47
1.07
0.09
1.4
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
8
74
1.09
0.07
1.4
1.9
nmol/l
274.5
362.7
—
8
69
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
23
217
1.08
0.06
2.4
2.8
ug/l
1.3
1.5
0.29
17
201
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
76
766
0.97
0.00
3.8
3.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
23
228
1.01
0.00
3.2
2.2
—
—
—
0
0
(3013512) EKG study
16
159
1.01
0.00
3.6
2.7
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806118)
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
31.4
—
0
9
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(44790047)
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(44790049)
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(44790048)
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
280.8
—
0
6
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.1
—
0.8
—
0
8
(1175426) CD3 cells/100 lymphocytes in Blood
0
5
0.00
0.00
0.0
4.8
—
77.2
—
0
5
(3023420) DNA double strand Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.4
—
50.0
—
0
7
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
0.3
—
0
5
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
38.5
—
0
6
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
2.1
—
0
7
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
6.3
—
0
6
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4281824)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
19.8
—
0
5
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(44813793)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
0
5
0.00
0.00
0.0
2.6
—
0.6
—
0
5
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
0.2
—
0
5
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
1190.2
—
0
6
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(4024509)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
8
0.00
0.00
0.0
2.5
—
4.1
—
0
8
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
178.2
—
0
6
(40768441) Liver Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
898.3
—
0
6
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
0.9
—
0
6
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
8
0.00
0.00
0.0
2.5
—
106.5
—
0
8
Mortality – FinRegistry
↥Association
Association between endpoint F5_SOLVENT and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_SOLVENT | 5.861 [3.8, 9.04] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 151 out of 599 males with F5_SOLVENT died.
Mortality risk
Mortality risk for people of age
years, who have F5_SOLVENT.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 1.15% |
| 5 | No data | 6.035% |
| 10 | No data | 15.889% |
| 15 | No data | 27.945% |
| 20 | No data | 43.88% |
Relationships between endpoints
↥Index endpoint: F5_SOLVENT – Mental and behavioural disorders due to use of volatile solvents
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data